During the past decade, Langlade Memorial Hospital conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 13 clinical trials were completed, i.e. on average, 650% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 5 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Langlade Memorial Hospital" #1 sponsor was "Alliance for Clinical Trials in Oncology" with 4 trials, followed by "ECOG-ACRIN Cancer Research Group" with 3 trials sponsored, "Eastern Cooperative Oncology Group" with 3 trials sponsored, "SWOG Cancer Research Network" with 2 trials sponsored and "ETOP IBCSG Partners Foundation" with 2 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Langlade Memorial Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 16 trials as a collaborator, "SWOG Cancer Research Network" with 2 trials as a collaborator, "Aptuit" with 1 trials as a collaborator, "Astellas Pharma Inc" with 1 trials as a collaborator and "Breast International Group" with 1 trials as a collaborator. Other collaborators include 2 different institutions and companies that were collaborators in the rest 12 trials.

According to Clinical.Site data, the most researched conditions in "Langlade Memorial Hospital" are "Breast Cancer" (4 trials), "Colorectal Cancer" (4 trials), "Prostate Cancer" (4 trials), "Metastatic Cancer" (2 trials) and "Stage IV Breast Cancer" (2 trials). Many other conditions were trialed in "Langlade Memorial Hospital" in a lesser frequency.

Most popular intervention types in "Langlade Memorial Hospital" are "Drug" (15 trials), "Biological" (5 trials), "Other" (4 trials), "Radiation" (3 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "placebo" (4 trials), "cetuximab" (2 trials), "docetaxel" (2 trials), "tamoxifen" (2 trials) and "zoledronic acid" (2 trials). Other intervention names were less common.

The vast majority of trials in "Langlade Memorial Hospital" are 11 trials for "All" genders, 5 trials for "Male" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Langlade Memorial Hospital". undefined are not yet recruiting, 2 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Langlade Memorial Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Langlade Memorial Hospital, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".